Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents

RI is an independent predictor of 30-day and 12-month MACE and death after PCI in patients with stable and unstable coronary syndromes, even with widespread use of DES. eGFR should be used to help risk-stratify patients undergoing PCI.